| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/30/2009 | EP2104534A1 New combination for use in the treatment of inflammatory disorders |
| 09/30/2009 | EP2104533A2 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases |
| 09/30/2009 | EP2104514A2 Insulin-like growth factor-1 receptor antagonists for modulation of weight and liposity |
| 09/30/2009 | EP2104504A2 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 09/30/2009 | EP2104503A1 Morpholine dopamine agonists for the treatment of pain |
| 09/30/2009 | EP2104502A1 Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives |
| 09/30/2009 | EP2104500A2 Substituted piperizines for the treatment of pain |
| 09/30/2009 | EP2104499A1 Method and composition for reducing reperfusion injury |
| 09/30/2009 | EP2104498A2 Liquid formulations of phospholipase enzyme inhibitors |
| 09/30/2009 | EP2104497A2 Urea and sulfamide derivatives as tafia inhibitors |
| 09/30/2009 | EP2104496A2 Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component |
| 09/30/2009 | EP2104495A2 Methods of administering rapamycin analogs with anti-inflammatories using medical devices |
| 09/30/2009 | EP2104494A1 Method for reducing inflammatory responses and inflammation |
| 09/30/2009 | EP2104493A2 Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse |
| 09/30/2009 | EP2104491A2 Hydrobromide salt of an anti-hiv compound |
| 09/30/2009 | EP2104490A2 Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
| 09/30/2009 | EP2104428A2 Combination product for controlling parasites on animals |
| 09/30/2009 | EP2104426A1 Agents for controlling parasites on animals |
| 09/30/2009 | EP2104424A2 Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa |
| 09/30/2009 | EP2041082B1 Pyrrolidine derivatives having activity at the glyt1 transporter |
| 09/30/2009 | EP1963355B1 New cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and preparation process |
| 09/30/2009 | EP1962849B1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 09/30/2009 | EP1940844B1 Compounds and compositions as protein kinase inhibitors |
| 09/30/2009 | EP1910376B1 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 09/30/2009 | EP1897545B1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 09/30/2009 | EP1776336B1 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
| 09/30/2009 | EP1768667B1 Cannabinoid receptor ligands |
| 09/30/2009 | EP1745011B1 Modulators of cannabinoid receptors |
| 09/30/2009 | EP1711181B1 Quinoline derivatives and use thereof as mycobacterial inhibitors |
| 09/30/2009 | EP1692117B1 Oxazole derivatives of tetracyclines |
| 09/30/2009 | EP1691802B1 Methods for the amelioration of environmental oxidant stress and the regulation of beneficial genes |
| 09/30/2009 | EP1658066B1 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 09/30/2009 | EP1611129B1 Cyclic sulfamides for inhibition of gamma-secretase |
| 09/30/2009 | EP1581523B1 Pyrazole-derivatives as factor xa inhibitors |
| 09/30/2009 | EP1554290B1 Analogs and prodrugs of buprenorphine |
| 09/30/2009 | EP1553089B1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 09/30/2009 | EP1549658B1 Glucose-based compounds with affinity to p-selectin |
| 09/30/2009 | EP1530480B1 Cosmetic composition comprising monosaccharides or polysaccharides, uses and treatment methods |
| 09/30/2009 | EP1530465B1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 09/30/2009 | EP1478650B1 Novel boronate esters |
| 09/30/2009 | EP1471892B1 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 09/30/2009 | EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 09/30/2009 | EP1404300B1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 09/30/2009 | EP1389122B1 Prevention of epithelial cancer |
| 09/30/2009 | EP1349549B1 Novel medicament compositions based on salts of tiotropium and on ciclesonide |
| 09/30/2009 | EP1309627B1 Immunotherapy for chronic myelocytic leukemia with naked anti-nca-90 antibody |
| 09/30/2009 | EP1261347B1 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 09/30/2009 | EP1240325B1 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 09/30/2009 | CN101547697A Treatment of occlusive thrombosis |
| 09/30/2009 | CN101547696A Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 09/30/2009 | CN101547695A Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 09/30/2009 | CN101547694A Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 09/30/2009 | CN101547693A An Alzheimer's disease progression inhibitor containing heterocyclic compound having specific structure |
| 09/30/2009 | CN101547692A Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound having specific structure |
| 09/30/2009 | CN101547691A Antiarteriosclerosis agents |
| 09/30/2009 | CN101547690A Dietary supplement, anti-fatigue agent or physical endurance enhancer, functional food, or cosmetic |
| 09/30/2009 | CN101547689A Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 09/30/2009 | CN101547688A Use of LXR agonists for the treatment of osteoarthritis |
| 09/30/2009 | CN101544953A Oxytropis Ehrig cinerea FEL2-OG and separation method and application thereof |
| 09/30/2009 | CN101544952A Oxytropis ehrig cinerea FEL4-OOc and separation method and application thereof |
| 09/30/2009 | CN101544706A Method for hierarchical barrier separation fine purification medicinal dextran based on repeated washing treatment |
| 09/30/2009 | CN101544681A New anti-tumor compound holothuria nobilis selenka saponin octyl of holothuria nobilis selenka |
| 09/30/2009 | CN101544680A New anti-tumor compound holothuria nobilis selenka saponin nonan of holothuria nobilis selenka |
| 09/30/2009 | CN101544678A Formulation and use of ergosta-7,22-dien-3beta-ol |
| 09/30/2009 | CN101544670A Saccharine adefovir dipivoxil and preparation method thereof |
| 09/30/2009 | CN101544662A Cefotiam salt compound and pharmaceutical composition made therefrom |
| 09/30/2009 | CN101544661A Cefobutazine sodium compound and pharmaceutical composition made therefrom |
| 09/30/2009 | CN101544654A Dimer (5-methylol-furfural), synthetic method thereof and medical application thereof |
| 09/30/2009 | CN101544652A Thiourea homologues epipodophyllotoxin compound and preparation method and application thereof |
| 09/30/2009 | CN101544644A Preparation method of mianserin hydrochloride |
| 09/30/2009 | CN101544642A 4-pteridine-ammonia compound and preparation and application thereof |
| 09/30/2009 | CN101544638A Lact-pyrondridin and its pharmaceutical composition |
| 09/30/2009 | CN101544634A 2-phenyl-3-substituted pyrazolo[1,5-a]pyridine derivatives, preparation method and application thereof |
| 09/30/2009 | CN101544631A Novel pyrazole 5-lipoxygenase small molecule inhibitors, preparation method, pharmaceutical composition and application thereof |
| 09/30/2009 | CN101544630A Hydroxylated indinavir, preparation method of hydroxylated indinavir, and application of hydroxylated indinavir in preparation of antimalarials |
| 09/30/2009 | CN101544624A 5-methylol-furfural-5-furfural-methanol, preparation method thereof and medical application thereof |
| 09/30/2009 | CN101544614A Phosphodiesterase III inhibitor, method for preparing same and medicinal application thereof |
| 09/30/2009 | CN101544610A Ligustrazine salt |
| 09/30/2009 | CN101544609A Crystallization form of 4-anilinoquinazoline derivatives |
| 09/30/2009 | CN101544602A Fleroxacin lactate and preparation method thereof |
| 09/30/2009 | CN101544597A Method for preparing amlodipine |
| 09/30/2009 | CN101544596A Preferred crystal-form substance of nitrendipine and preparation method, pharmaceutical composition and application thereof |
| 09/30/2009 | CN101544592A N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 09/30/2009 | CN101544579A Use and preparation method of 4-(-2-acetoxybenzoyl)aminobutyric acid and ester derivative thereof |
| 09/30/2009 | CN101544578A Preparing method for phenyl acetic acid derivates and applications in medicament |
| 09/30/2009 | CN101544572A Ambroxol derivative and method for preparing same |
| 09/30/2009 | CN101544556A Quinone compound Bostrycin, preparation method thereof and anti-tumor application thereof |
| 09/30/2009 | CN101544542A Depigmentation agents |
| 09/30/2009 | CN101543659A Local vascular delivery system of probucol alone or in combination with sirolimus |
| 09/30/2009 | CN101543658A Cervical cap for preventing and treating cervical erosion and preparation method thereof |
| 09/30/2009 | CN101543632A Anti-tumor prodrug having accurate structure and taking novel amphipathic polymer as carrier and synthetic method thereof |
| 09/30/2009 | CN101543631A Microspherical substrate containing beeswax, pharmaceutical composition containing microspherical substrate and application thereof |
| 09/30/2009 | CN101543628A Medicament and preparation thereof for treating hyperlipemia and atherosclerosis |
| 09/30/2009 | CN101543626A Medicament for preventing and curing thrombus and preparation method thereof |
| 09/30/2009 | CN101543604A External traditional-Chinese-medicine patch for preventing dizziness |
| 09/30/2009 | CN101543601A Compound pharmaceutical composition for preventing and curing respiratory diseases in animals and preparation method thereof |
| 09/30/2009 | CN101543600A Acarid killing gel and preparation method thereof |
| 09/30/2009 | CN101543599A Medicine for curing hypertension and preparation method thereof |
| 09/30/2009 | CN101543589A Compound pharmaceutical composition for curing virus diseases of animals and preparation method thereof |
| 09/30/2009 | CN101543582A Chinese medicinal ointment for treating osteopathy |